Purdue University research instrumental in early development of FDA-approved advanced prostate cancer diagnostic and treatment

Prostate cancer is the second-most common cancer among American men after nonmelanoma skin cancer. According to the Centers for Disease Control and Prevention, it's also among the leading causes of cancer deaths in men.

Related Keywords

United States ,American ,Ralphc Corley ,Timothyl Ratliff ,Robert Wallace Miller ,Brooke Beier ,Steve Martin ,Purdue University ,Centers For Disease ,Us Services ,Purdue Research Foundation Office Of Technology Commercialization ,Institute For Drug Discovery ,Drug Administration ,Ipwatchdog Institute ,Association Of Public ,Office Of Technology Commercialization ,Cancer Research ,Purdue Research Foundation ,Purdue Center ,Purdue Institute For Drug Discovery ,National Cancer ,Convergence Center ,Disease Control ,Philip Low ,Presidential Scholar ,Drug Discovery ,Distinguished Professor ,Purdue University College ,Purdue Research Foundation Office ,Technology Commercialization ,Purdue Institute ,Yin Zhang ,National Cancer Institute Designed ,Robert Wallace Miller Director ,Target Laboratories ,Discovery Park District ,Economic Prosperity Universities Award ,